AM Rx Review
Best for: patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully)
AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx). Offers compounded semaglutide from $151/mo quarterly and brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/mo. Video and async consultations available. HSA/FSA accepted.
Medium confidence · Last verified 2026-04-10 via WebFetch multi-page scrape · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
AM Rx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
AM Rx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Brand GLP-1 with insurance | brand | $25 |
| Compounded Semaglutide (quarterly) | compounded | $151 |
✓ Pros
- •Insurance coordination for brand-name GLP-1s — as low as $25/mo
- •All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- •HSA and FSA accepted
- •Video visits available (not just async) with providers averaging 10+ years experience
- •Compounded semaglutide from $151/mo quarterly
✗ Cons
- •Active FTC/DOJ lawsuit for deceptive billing and subscription practices (ROSCA violations)
- •Two FDA warning letters (Sept 2025, Feb 2026) for misbranding compounded GLP-1 products
- •Novo Nordisk false advertising lawsuit (Aug 2025)
- •Parent entity Zealthy has BBB D- rating with 2,370+ complaints
- •Trustpilot 2.0/5 — 85% one-star reviews citing billing disputes and unreachable support
- •No visible LegitScript certification or PCAB accreditation
- •No named pharmacy partners — compounding source not disclosed
- •No FDA compounding disclaimer on the website
- •State availability not publicly disclosed
- •Founder Kyle Robertson previously ran Cerebral, which settled FTC charges for similar practices
- •Same corporate entity (FitRX LLC) as Zealthy and FitRx — shares regulatory history
Ready to start with AM Rx?
Starting at $25/month. See current pricing and start your free consultation.
Sources & methodology
Our AM Rx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to AM Rx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Ready to start with AM Rx?
Starting at $25/month. See current pricing and start your free consultation.